GLP-1 receptor agonists have established compelling evidence for the commercial value of multi-indication drug development beyond obesity. Conventional paradigms for drug development must shift in order to adapt to multi...
Press releases
-
ICON completes acquisition of MediMedia Pharma Solutions
Extends ICON’s leadership in commercialisation and market access services and brings new scientific communications capabilities
-
ICON to acquire MediMedia Pharma Solutions
The acquisition strengthens ICON’s expertise in scientific communications and market access
